skim milk cd9 Search Results


skim milk cd9  (Proteintech)
96
Proteintech skim milk cd9
Skim Milk Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/skim milk cd9/product/Proteintech
Average 96 stars, based on 1 article reviews
skim milk cd9 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
cd9 antibody  (Abcam)
96
Abcam cd9 antibody
<t>CD9</t> is the candidate regulator in glaucoma and overexpression of CD9 maintained TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM and GTM 3 cells. n = 6. (B‐C) Protein expression of CD9 in iHTM and GTM 3 cells. n = 6. D, Real‐time PCR result of CD9 mRNA in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (E‐F) Protein expression of CD9 in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < 0.05 vs iHTM group, # P < .05 vs GTM 3 group. G, Immunostaining of Vimentin and Tubulin in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups
Cd9 Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9 antibody/product/Abcam
Average 96 stars, based on 1 article reviews
cd9 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
184 antibodies against bax  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc 184 antibodies against bax
<t>CD9</t> is the candidate regulator in glaucoma and overexpression of CD9 maintained TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM and GTM 3 cells. n = 6. (B‐C) Protein expression of CD9 in iHTM and GTM 3 cells. n = 6. D, Real‐time PCR result of CD9 mRNA in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (E‐F) Protein expression of CD9 in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < 0.05 vs iHTM group, # P < .05 vs GTM 3 group. G, Immunostaining of Vimentin and Tubulin in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups
184 Antibodies Against Bax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/184 antibodies against bax/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
184 antibodies against bax - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd9 anti rabbit  (Danaher Inc)
86
Danaher Inc cd9 anti rabbit
<t>CD9</t> is the candidate regulator in glaucoma and overexpression of CD9 maintained TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM and GTM 3 cells. n = 6. (B‐C) Protein expression of CD9 in iHTM and GTM 3 cells. n = 6. D, Real‐time PCR result of CD9 mRNA in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (E‐F) Protein expression of CD9 in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < 0.05 vs iHTM group, # P < .05 vs GTM 3 group. G, Immunostaining of Vimentin and Tubulin in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups
Cd9 Anti Rabbit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9 anti rabbit/product/Danaher Inc
Average 86 stars, based on 1 article reviews
cd9 anti rabbit - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
cd9  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology cd9
Characterization of sEVs released by ARPE-19 cells. Nanoparticle tracking analysis and TEM were used to analyze the size distribution, morphology and to quantify sEVs in ARPE-19 cells under both control conditions ( A ) and high glucose treatment ( B ). Scale bar 200 nm. Difference between number of control sEVs and 35 mM glucose sEVs is presented in particles/mL ( C ). Western blot analysis shows <t>CD9,</t> CD63 and β-Actin expression in sEVs, lysate and cell supernatant ( D ). Values are presented as mean ± SEM ( n = 5). p -value was determined using two-tailed t-test * p < 0.05.
Cd9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
cd9 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CD9 is the candidate regulator in glaucoma and overexpression of CD9 maintained TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM and GTM 3 cells. n = 6. (B‐C) Protein expression of CD9 in iHTM and GTM 3 cells. n = 6. D, Real‐time PCR result of CD9 mRNA in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (E‐F) Protein expression of CD9 in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < 0.05 vs iHTM group, # P < .05 vs GTM 3 group. G, Immunostaining of Vimentin and Tubulin in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups

Journal: Journal of Cellular and Molecular Medicine

Article Title: Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

doi: 10.1111/jcmm.14792

Figure Lengend Snippet: CD9 is the candidate regulator in glaucoma and overexpression of CD9 maintained TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM and GTM 3 cells. n = 6. (B‐C) Protein expression of CD9 in iHTM and GTM 3 cells. n = 6. D, Real‐time PCR result of CD9 mRNA in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (E‐F) Protein expression of CD9 in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < 0.05 vs iHTM group, # P < .05 vs GTM 3 group. G, Immunostaining of Vimentin and Tubulin in iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups

Article Snippet: After the membranes were incubated with 5% skim milk at room temperature for 1 hour, CD9 antibody (1:1000, ab92726; Abcam), ITGA4 antibody (1:1000, ab81280; Abcam), p‐PI3K antibody (1:1000, ab182651; Abcam), PI3K antibody (1:1000, ab86714; Abcam), p‐Akt antibody (1:1000, ab38449; Abcam) or Akt antibody (1:500, ab8805; Abcam) was added.

Techniques: Over Expression, Real-time Polymerase Chain Reaction, Expressing, Immunostaining

Knock‐down of CD9 changed TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. n = 6. (B‐C) Protein expression of CD9 in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. n = 6. * P < .05 vs iHTM group, # P < .05 vs iHTM + siRNA group. D, Immunostaining of Vimentin and Tubulin in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups

Journal: Journal of Cellular and Molecular Medicine

Article Title: Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

doi: 10.1111/jcmm.14792

Figure Lengend Snippet: Knock‐down of CD9 changed TM cell identity. A, Real‐time PCR result of CD9 mRNA in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. n = 6. (B‐C) Protein expression of CD9 in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. n = 6. * P < .05 vs iHTM group, # P < .05 vs iHTM + siRNA group. D, Immunostaining of Vimentin and Tubulin in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups

Article Snippet: After the membranes were incubated with 5% skim milk at room temperature for 1 hour, CD9 antibody (1:1000, ab92726; Abcam), ITGA4 antibody (1:1000, ab81280; Abcam), p‐PI3K antibody (1:1000, ab182651; Abcam), PI3K antibody (1:1000, ab86714; Abcam), p‐Akt antibody (1:1000, ab38449; Abcam) or Akt antibody (1:500, ab8805; Abcam) was added.

Techniques: Real-time Polymerase Chain Reaction, Expressing, Immunostaining

CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma. (A,B) Protein expression of ITGA4 in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,C) Protein expression of p‐PI3K in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,D) Protein expression of p‐Akt in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,E) Protein expression of clevage caspase3 in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < .05 vs iHTM group, # P < .05 vs GTM 3 group. (F‐G) FCAS results of cells from iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 3. * P < .05 vs iHTM group, # P < .05 vs GTM 3 group

Journal: Journal of Cellular and Molecular Medicine

Article Title: Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

doi: 10.1111/jcmm.14792

Figure Lengend Snippet: CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma. (A,B) Protein expression of ITGA4 in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,C) Protein expression of p‐PI3K in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,D) Protein expression of p‐Akt in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. (A,E) Protein expression of clevage caspase3 in GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 6. * P < .05 vs iHTM group, # P < .05 vs GTM 3 group. (F‐G) FCAS results of cells from iHTM, GTM 3 , GTM 3 + CD9 and GTM 3 + pcDNA3.1 groups. n = 3. * P < .05 vs iHTM group, # P < .05 vs GTM 3 group

Article Snippet: After the membranes were incubated with 5% skim milk at room temperature for 1 hour, CD9 antibody (1:1000, ab92726; Abcam), ITGA4 antibody (1:1000, ab81280; Abcam), p‐PI3K antibody (1:1000, ab182651; Abcam), PI3K antibody (1:1000, ab86714; Abcam), p‐Akt antibody (1:1000, ab38449; Abcam) or Akt antibody (1:500, ab8805; Abcam) was added.

Techniques: Expressing

CD9/ITGA4/PI3K‐Akt axis participating in regulating glaucoma. A, Protein expression of ITGA4, PI3K, Akt and caspase‐3 in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. B, Protein expression of ITGA4, PI3K, Akt and caspase‐3 in GTM 3 + CD9, GTM 3 + CD9+si‐ITGA4 and GTM 3 + CD9+si‐NC groups. C, Mimic mechanism pathway of CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

Journal: Journal of Cellular and Molecular Medicine

Article Title: Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

doi: 10.1111/jcmm.14792

Figure Lengend Snippet: CD9/ITGA4/PI3K‐Akt axis participating in regulating glaucoma. A, Protein expression of ITGA4, PI3K, Akt and caspase‐3 in iHTM, iHTM + siRNA, iHTM + si‐NC and GTM 3 groups. B, Protein expression of ITGA4, PI3K, Akt and caspase‐3 in GTM 3 + CD9, GTM 3 + CD9+si‐ITGA4 and GTM 3 + CD9+si‐NC groups. C, Mimic mechanism pathway of CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma

Article Snippet: After the membranes were incubated with 5% skim milk at room temperature for 1 hour, CD9 antibody (1:1000, ab92726; Abcam), ITGA4 antibody (1:1000, ab81280; Abcam), p‐PI3K antibody (1:1000, ab182651; Abcam), PI3K antibody (1:1000, ab86714; Abcam), p‐Akt antibody (1:1000, ab38449; Abcam) or Akt antibody (1:500, ab8805; Abcam) was added.

Techniques: Expressing

Characterization of sEVs released by ARPE-19 cells. Nanoparticle tracking analysis and TEM were used to analyze the size distribution, morphology and to quantify sEVs in ARPE-19 cells under both control conditions ( A ) and high glucose treatment ( B ). Scale bar 200 nm. Difference between number of control sEVs and 35 mM glucose sEVs is presented in particles/mL ( C ). Western blot analysis shows CD9, CD63 and β-Actin expression in sEVs, lysate and cell supernatant ( D ). Values are presented as mean ± SEM ( n = 5). p -value was determined using two-tailed t-test * p < 0.05.

Journal: International Journal of Molecular Sciences

Article Title: Role of Exosomal miR-205-5p Cargo in Angiogenesis and Cell Migration

doi: 10.3390/ijms25020934

Figure Lengend Snippet: Characterization of sEVs released by ARPE-19 cells. Nanoparticle tracking analysis and TEM were used to analyze the size distribution, morphology and to quantify sEVs in ARPE-19 cells under both control conditions ( A ) and high glucose treatment ( B ). Scale bar 200 nm. Difference between number of control sEVs and 35 mM glucose sEVs is presented in particles/mL ( C ). Western blot analysis shows CD9, CD63 and β-Actin expression in sEVs, lysate and cell supernatant ( D ). Values are presented as mean ± SEM ( n = 5). p -value was determined using two-tailed t-test * p < 0.05.

Article Snippet: After blocking with 5% skim milk, membranes were incubated overnight with CD9 (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and CD63 antibodies (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA).

Techniques: Western Blot, Expressing, Two Tailed Test